ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159
Not Applicable
Completed
- Conditions
- Peripheral Stem Cell/Marrow Transplant
- Registration Number
- NCT00168168
- Lead Sponsor
- Alberta Health services
- Brief Summary
Evaluate recovery time on 2.5 mg/Kg/day dose of G-CSF versus 5 mg/Kg/day dose.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- over age 18
- autologous stem cell/marrow transplant candidate in MM, lymphoma, AMG and testicular
Exclusion Criteria
- age below 18 years
- sensitive to G-CSF
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Cross Cancer Institute
🇨🇦Edmonton, Alberta, Canada